Standard Newswire is a cost-effective and efficient newswire service for public policy groups, government agencies, PR firms, think-tanks, watchdog groups, advocacy groups, coalitions, foundations, colleges, universities, activists, politicians, and candidates to distribute their press releases to journalists who truly want to hear from them.
Do not settle for an email blasting service or a newswire overloaded with financial statements. Standard Newswire gets your news into the hands of working journalists, broadcast hosts, and news producers.
Find out how you can start using Standard Newswire to
Do not settle for an email blasting service or a newswire overloaded with financial statements. Standard Newswire gets your news into the hands of working journalists, broadcast hosts, and news producers.
Find out how you can start using Standard Newswire to
Sign Up to Receive Press Releases:
Standard Newswire™ LLC
209 W. 29th Street, Suite 6202
New York, NY 10001, USA.
(212) 290-1585
Patient Rights at the Center of a New Report by Dr. Nalini M. Rajamannan
Most Sacred Heart of Jesus Cardiology and Valvular Institute
May 10, 2019
CHICAGO, May 10, 2019 /Standard Newswire/ -- The final clues are falling into place in a 12-year-old mystery about how patient protections were bypassed during open heart surgery for hundreds of patients. The Model 5100 heart valve ring was implanted into nearly 700 patients without their consent or approval from the Food and Drug Administration. Documents recently obtained through a Freedom of Information Act request outline how this practice escaped regulatory notice.
On Thursday, one of the Model 5100 patients was in a Chicago courtroom, seeking a new trial in a malpractice lawsuit due to the newly released documents. Her petition alleges fraudulent concealment of critical information, which is now public.
"He was putting it into patients, seeing how it worked, and not telling them," Obermeier's attorney Adrwin Boyer said during opening statements of the 2016 court trial in Cook County, according to Fox 32 in Chicago.
Dr. Nalini M. Rajamannan's report, The Myxo File X and The Myxo Report, offers a comprehensive look at the Senate Finance and Senate Judiciary Investigations from 2008-2014 for the 667 heart valve patients, media, regulators, lawmakers and patients' rights advocates.
The Myxo File X published Saturday, May 4, 2019 on Amazon.com also provides an in-depth analysis by Dr. Rajamannan, an eye-witness to the human experiments, regarding the release of responses sent to the Senate.
Link to The Myxo Report:
https://www.amazon.com/dp/B07RFDTMWH
https://www.amazon.com/Myxo-Report-Experimentation-Northwestern-University-ebook/dp/B07QWFG24J
https://www.scribd.com/document/407458228/FOIA-FDA-12-18-2018-IHS
https://www.scribd.com/document/399069069/Final-FDA-MEETING-JMJ
This release is a summary of the legal brief submitted in the appellate court of Illinois, First District case number 1-17-0533 which is an extension of the circuit court case 08-L012426 in the circuit court of cook county. The appellate court will hear the oral arguments in June 2019.
Dr. Nalini Rajamannan is a heart valve expert in the field of cardiovascular medicine. She has been researching heart valve disease for 31 years. She earned her undergraduate science pre-professional degree from the University of Notre Dame, her Medical Doctorate from Mayo Medical School and her post-graduate training in Internal Medicine and Cardiology at the Mayo Clinic. She also worked at the Mayo Clinic as a staff consultant in Internal Medicine. Currently, she practices consultative medicine specializing in Cardiac Valvular Heart Disease at Most Sacred Heart of Jesus Cardiology and Valvular Institute, WI.
SOURCE Most Sacred Heart of Jesus Cardiology and Valvular Institute
CONTACT: Dr. Nalini M. Rajamannan, 312-498-9496
